EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of human transplacental transfer of escitalopram, sertraline and paroxetine: an ex vivo cotyledon perfusion study

Laure-Hélène Préta, Naïm Bouazza, Frantz Foissac, Léo Froelicher, Saïk Urien, Annouk Dauvilliers, Alisha Dinnall, Victoria Buth, Sihem Benaboud, Jean-Marc Tréluyer, Gabrielle Lui

Placenta · 2025

DOI: 10.1016/j.placenta.2025.06.015 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Placenta, 2025. Verfasst von Laure-Hélène Préta und 10 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, 75006, Paris, France. Electronic a…. Hauptthemen laut MEDLINE: Sertraline, Paroxetine, Maternal-Fetal Exchange, Placenta. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Non-US Government Research Support type, Institut National de la Santé et de la Recherche Médicale, GIS-FC3R.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Depression is common in pregnant women and the decision to treat must consider potential risk to the fetus. Since data on the transplacental transfer of serotonin reuptake inhibitors (SSRIs) remain sparse, we aimed to characterize and compare the transplacental transfer of three commonly used SSRIs in pregnant women: escitalopram, sertraline and paroxetine. METHODS: Ex vivo human placental perfusions in dual recirculating configuration were performed for these three antidepressants with and without albumin over 3 h of perfusion. Antidepressants were quantified by liquid chromatography-mass spectrometry (LC-MS) in maternal and fetal compartments. RESULTS: Our results showed that the three drugs crossed the placental barrier. In presence of albumin, we determined a median [IQR] fetal transfer rate (FTR) of 48.2 % [46.2-49.2] for escitalopram, 43.4 % [32.7-45.2] for paroxetine and 33.2 % for sertraline [30.7-36.9]. Thus, escitalopram crossed the placenta significantly more than sertraline (p = 0.008). Paroxetine had an intermediate placental transfer rate, but this was not statistically different from the other two drugs. Based on fetal transfer rate values, the transplacental transfer of antidepressants seemed to be increased in presence of albumin, but this effect was significant only for sertraline (p = 0.009). CONCLUSIONS: The present study is the first one that compared the human placental transfer of escitalopram, sertraline and paroxetine, using the same conditions of ex vivo perfusion. Our results are consistent with in vivo data, confirming the relevance of ex vivo placental perfusion for evaluating transplacental transfer, and highlighting the importance of adding albumin to the perfusion medium, particularly for highly protein-bound drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SertralineParoxetineMaternal-Fetal ExchangePlacentaSelective Serotonin Reuptake InhibitorsEscitalopramHumansFemalePregnancyPerfusionAdult

Stichwörter der Autor:innen

AntidepressantEx vivoFetal exposurePregnancyTransplacental tranfer

Substanzen

SertralineParoxetineSelective Serotonin Reuptake InhibitorsEscitalopram

Autor:innen und Institutionen

  • Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, 75006, Paris, France. Electronic address: laurehelene.preta@aphp.fr.
  • Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, 75006, Paris, France; Unité de Recherche Clinique, Université Paris Cité Necker/Cochin, Hôpital Tarnier,…
  • Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, 75006, Paris, France; Service de Pharmacologie Clinique, Hôpital Cochin, AP-HP, Groupe Hospitalier Paris…
  • Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, 75006, Paris, France.
  • Centre d'Investigation Clinique P1419, Université Paris Cité Necker/Cochin, Hôpital Cochin-Maternité Port-Royal, Paris, France.
  • Université Paris Cité, Inserm, Pharmacologie et évaluations des thérapeutiques chez l'enfant et la femme enceinte, 75006, Paris, France; Centre d'Investigation Clinique P1419, Université Paris Cité Necker/Cochin, Hôpita…

Förderung

  • Non-US Government Research Support type
  • Institut National de la Santé et de la Recherche Médicale
  • GIS-FC3R
  • Foundation for Medical Research

Zitieren

APA

Préta, L. H., Bouazza, N., Foissac, F., Froelicher, L., Urien, S., Dauvilliers, A., Dinnall, A., Buth, V., Benaboud, S., Tréluyer, J. M., & Lui, G. (2025). Comparison of human transplacental transfer of escitalopram, sertraline and paroxetine: an ex vivo cotyledon perfusion study. Placenta. https://doi.org/10.1016/j.placenta.2025.06.015

Vancouver

Préta LH, Bouazza N, Foissac F, Froelicher L, Urien S, Dauvilliers A, et al. Comparison of human transplacental transfer of escitalopram, sertraline and paroxetine: an ex vivo cotyledon perfusion study. Placenta. 2025. doi:10.1016/j.placenta.2025.06.015

BibTeX
@article{Prta2025,
  author = {Préta, Laure-Hélène and Bouazza, Naïm and Foissac, Frantz and Froelicher, Léo and Urien, Saïk and Dauvilliers, Annouk and Dinnall, Alisha and Buth, Victoria and Benaboud, Sihem and Tréluyer, Jean-Marc and Lui, Gabrielle},
  title = {Comparison of human transplacental transfer of escitalopram, sertraline and paroxetine: an ex vivo cotyledon perfusion study},
  journal = {Placenta},
  year = {2025},
  doi = {10.1016/j.placenta.2025.06.015}
}
Kostenlos starten →